{"id":"W4415942575","doi":"10.1016/j.annonc.2025.08.1043","title":"621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tolerability; Breast cancer; Limiting; Phases of clinical research; Cancer; Topoisomerase; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008835404,0.001259048,0.0013059,0.000320638,0.0003247852,0.001005213,0.0008887351,0.00109974,0.006706785],"category_scores_gemma":[0.0004403783,0.0004351863,0.0008606403,0.0004210164,0.0006763938,0.0006074593,0.000390499,0.003373195,0.001981704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001057271,"about_ca_system_score_gemma":0.001736284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002920316,"about_ca_topic_score_gemma":0.006948314,"domain_scores_codex":[0.9997967,0.00006402665,0.000009903273,0.00003456681,0.00002201134,0.00007275714],"domain_scores_gemma":[0.9997223,0.00002095124,0.00002942905,0.00001498923,0.00001427224,0.0001980354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5118895,0.04435636,0.00766212,0.001314068,0.001691257,0.0005304339,0.0003214662,0.004253731,0.0955747,0.001038797,0.02287716,0.3084905],"study_design_scores_gemma":[0.6519003,0.308708,0.01360906,0.00008574985,0.0006691494,0.0006955558,0.00008422099,0.002349564,0.007412737,0.0005572864,0.01387813,0.00005020756],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9784383,0.004617904,0.0007737835,0.001628525,0.0003194561,0.002867802,0.003382738,0.0004337615,0.007537839],"genre_scores_gemma":[0.9673994,0.004619653,0.002635394,0.002297477,0.0001893918,0.002656646,0.008925504,0.00009764038,0.01117889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006706785,"threshold_uncertainty_score":0.02243638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07087206971817465,"score_gpt":0.4770906131229302,"score_spread":0.4062185434047555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}